Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma
Liver Cancer · 03.03.2025 · 14 (5) · 651-678
DOI: 10.1159/000544976 ↗Kurz gefasst
Leitlinie in der Zeitschrift Liver Cancer, online erschienen am 03.03.2025. Verfasst von Shuichiro Shiina und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Juntendo University, Bunkyō, Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Globally, the incidence and associated mortality of primary liver cancer have been steadily increasing. Currently, 80% of cases are found in Asia. Curative resection is applicable in only 20% of patients; therefore, various nonsurgical treatment modalities have been developed. Image-guided percutaneous liver tumor ablation is regarded as the best option for treating early-stage hepatocellular carcinoma (HCC). However, skills and knowledge in ablation can vary among operators. Furthermore, Asia has the highest number of ablation procedures for HCC and the largest number of doctors performing ablation worldwide. Thus, the Asian Conference on Tumor Ablation has developed guidelines for HCC. These guidelines will discuss indications, pre-ablative diagnosis and planning, techniques, peri-ablative management, evaluation of therapeutic effectiveness, complications, post-ablative follow-up, prevention of recurrence, and treatment of recurrence for HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Juntendo University, Bunkyō, Japan.
- Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Bunkyō, Japan.
- Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
- Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
- Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Medical Imaging and Interventional Radiology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University, Guangzhou, China.
Zitieren
APA
Shiina, S., Tateishi, R., Choi, J. I., Kim, S. Y., Meng, Z., Shen, L., Lu, S. N., Hwang, J. I., Tobari, M., Maruyama, H., Batsaikhan, T., Deng, Q., Canseco, L. M., Asaoka, Y., Lin, S. M., Huang, K. W., Rhim, H., Liang, P., Pua, U., …, & Wu, P. (2025). Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma. Liver Cancer, 14(5), 651-678. https://doi.org/10.1159/000544976
Vancouver
Shiina S, Tateishi R, Choi JI, Kim SY, Meng Z, Shen L, et al. Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma. Liver Cancer. 2025;14(5):651-678. doi:10.1159/000544976
BibTeX
@article{Shiina2025,
author = {Shiina, Shuichiro and Tateishi, Ryosuke and Choi, Joon Il and Kim, So Yeon and Meng, Zhiqiang and Shen, Lujun and Lu, Sheng-Nan and Hwang, Jen-I and Tobari, Maki and Maruyama, Hitoshi and Batsaikhan, Terguunbileg and Deng, Qing and Canseco, Lariza Marie and Asaoka, Yoshinari and Lin, Shi-Ming and Huang, Kai-Wen and Rhim, Hyunchul and Liang, Ping and Pua, Uei and Tanaka, Masatoshi and Wu, Peihong},
title = {Asian Conference on Tumor Ablation Guidelines for Hepatocellular Carcinoma},
journal = {Liver Cancer},
year = {2025},
volume = {14},
number = {5},
pages = {651--678},
doi = {10.1159/000544976}
}
EUVIMED